| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_478397c5cb3e672ac682829605b7901a |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L2300-112
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L2430-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L2400-12 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L27-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L27-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-663
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L27-54
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L27-56
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L27-58 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-663
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L27-58
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L27-54
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L27-56
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L27-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L27-18 |
| filingDate |
2016-07-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2016-11-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1c50f4367272be9c37e69a5c2bcccc09
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f164fc39e703bca1b8fb4764e8fa507a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_756b9d1b8787b36dd3a8b9686e8df330 |
| publicationDate |
2016-11-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
KR-101680786-B1 |
| titleOfInvention |
Bone regeneration biomaterials and for manufacturing method thereof |
| abstract |
The biomaterial for bone regeneration according to the present invention and the method for producing the biomaterial for bone regeneration and the method for producing the same are capable of activating osteoblasts and killing osteoclasts using a biocompatible polymer material excellent in blood compatibility and cell tissue compatibility with natural bone and having the same structural or chemical composition And can inhibit bone loss and osteoporosis, and is potentially useful for the development of a drug delivery system as well as osteoporosis, and is used as a therapeutic agent for various bone diseases, thereby exhibiting a bone regeneration effect. In addition, the biomaterial for bone regeneration of the present invention and the method for producing the biomaterial for bone regeneration not only activate the osteoblast cell temporarily but also promote the interaction between the biomaterial and the bone tissue, do not exhibit cytotoxicity, The activity of osteoclasts can be controlled. In addition, it is possible to prevent the agglomeration of nanoparticles and to disperse evenly while maintaining the original particle size, so that excellent osteoblast proliferation promoting effect can be expected and excellent bone regeneration effect is exhibited. Therefore, instead of the existing artificial bone substitute, It can be very useful as a material. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20200094473-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-101992401-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-102233145-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-109999220-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-109930209-B
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20180099072-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-109930209-A |
| priorityDate |
2016-07-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |